DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Life ScienceLife Science
  4. /LinkersLinkers
  5. /GalNAc-LinkersGalNAc-Linkers
  6. /Trivalent GalNAc-DBCOTrivalent GalNAc-DBCO
Chemical structure of CAS 2765060-22-6

Trivalent GalNAc-DBCO

CAS No.2765060-22-6
MDL No.N/A
MFC91H144N12O34
MW1950.20
InChI KeyMUDHYUDVXOPWNN-IMTCGYAUSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.2765060-22-6
Product NameTrivalent GalNAc-DBCO
Heavy Atom Count137Rotatable Bond Count70
Atom Stereo Count15Bond Stereo Count0
HBA34HBD20
TPSA642.470 ŲCharge0
Exact Mass1948.99079Complexity3777.15
pKa7.130XLogP-5.380

Documentation

Similar Products

  • tri-GalNAc-COOH

    CAS No.1953146-81-0

  • Tris-GalNAc-b-PEG5-NHS ester

    CAS No.1953146-83-2

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact